Valuation: DMS

Market Cap 23.69M 26.62M 21.96M 19.9M 37.39M 2.52B 38.02M 263M 103M 1.32B 99.84M 97.77M 4.21B P/E 2026 *
45.8x
P/E 2027 * 10.2x
Enterprise Value 42.09M 47.29M 39.01M 35.35M 66.43M 4.48B 67.55M 468M 184M 2.34B 177M 174M 7.48B EV / Sales 2026 *
0.94x
EV / Sales 2027 * 0.58x
Free-Float
69.9%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 53 2022-07-17
Director of Finance/CFO - 2021-12-31
Chief Tech/Sci/R&D Officer - 2018-12-31
Director TitleAgeSince
Chairman 53 2022-07-17
Director/Board Member 52 2025-06-15
Director/Board Member - 2023-07-23
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 26.62M
+1.18%+3.67%+26.39%+48.03% 254B
-0.08%+0.63%+7.61%+8.94% 158B
+1.11%+3.78%-4.46%+64.10% 155B
+1.18%+5.24%-54.66%-8.93% 66.06B
+0.59%+5.65%+11.46%+59.02% 51.6B
+0.07%+3.39%-14.75%-11.79% 51.82B
+1.23%+3.54%+17.27%+27.07% 50.89B
+1.83%+0.82%+20.99%+58.39% 48.78B
+1.97%+3.18%+29.04%+74.59% 43.51B
Average +0.17%+3.37%+4.32%+35.49% 97.69B
Weighted average by Cap. -0.38%+3.20%+7.50%+37.36%

Financials

2026 *2027 *
Net sales 44.9M 50.44M 41.61M 37.71M 70.87M 4.78B 72.05M 499M 196M 2.5B 189M 185M 7.98B 60M 67.41M 55.61M 50.39M 94.7M 6.39B 96.29M 667M 262M 3.34B 253M 248M 10.66B
Net income 400K 449K 371K 336K 631K 42.57M 642K 4.45M 1.75M 22.28M 1.69M 1.65M 71.07M 2.3M 2.58M 2.13M 1.93M 3.63M 245M 3.69M 25.58M 10.05M 128M 9.69M 9.49M 409M
Net Debt 18.4M 20.67M 17.05M 15.45M 29.04M 1.96B 29.53M 205M 80.38M 1.02B 77.54M 75.93M 3.27B 10.9M 12.25M 10.1M 9.15M 17.2M 1.16B 17.49M 121M 47.62M 607M 45.93M 44.98M 1.94B
Logo DMS
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (49.6%), North and South America (17%), Asia (7.5%), Middle East (7.5%), Africa (3.1%), Oceania (1%) and other (14.3%).
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - DMS